Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Heart Failure NYHA Class IV: early-phase trial registry
4 of 6 indexed Heart Failure NYHA Class IV trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Heart Failure NYHA Class IV: 6 US clinical trials tracked, 4 recruiting.
Heart Failure NYHA Class IV is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Washington, running 2 of these trials.
Enrollment posture brief
Registry condition heart-failure-nyha-class-iv
OPEN 4 | RECR 67% | LATE 0 | EARLY 2 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)
Heart Failure NYHA Class IV lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Heart Failure NYHA Class IV on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Heart Failure NYHA Class IV is recruiting above its size-band peers.
4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Heart Failure NYHA Class IV research.
University of Washington accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Heart Failure NYHA Class IV enrolment sits around 208 participants.
Median target enrolment is 208 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Heart Failure NYHA Class IV research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
Yale University
NCT04237701
Sustaining Home Heart Failure Palliative Care in Rural Appalachia
West Virginia University
NCT06791850
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
HeartWorks
NCT05647213
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
University of Washington
NCT02537769
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
University of Washington
NCT04528004
Hemodynamic-GUIDEd Management of Heart Failure
Abbott Medical Devices
NCT03387813
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Heart Failure NYHA Class IV records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Heart Failure NYHA Class IV trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Heart Failure NYHA Class IV page
6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Heart Failure NYHA Class IV trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Washington sponsors the most Heart Failure NYHA Class IV trials on record, review their full trial history before evaluating a specific study. See University of Washington's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Heart Failure NYHA Class IV condition card totals 6 registered trials; most-linked intervention CardioMEMS™ HF System; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.